Acumen Pharmaceuticals
ABOS
ABOS
47 hedge funds and large institutions have $120M invested in Acumen Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 20 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
42% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 19
50% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 20
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $82K
Holders
47
Holding in Top 10
1
Calls
–
Puts
$82K
Top Buyers
| 1 | +$2.76M | |
| 2 | +$2.76M | |
| 3 | +$2.58M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$2.35M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$138K |
Top Sellers
| 1 | -$5.35M | |
| 2 | -$2.82M | |
| 3 | -$1.44M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$1.13M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.1M |